Rodents have frequently been used as a model for understanding brain functions. One of the main advantages in using mice is that genetic-phenotypic association can be directly addressed by generating genetically engineered animals, such as knockout and transgenic mice. Nonetheless, pairwise alignments of nearly 13 000 orthologous gene pairs indicated that the encoded proteins have a median amino-acid sequence identity of 78.5% between humans and mice, 1 whereas the sequence identity between humans and rhesus monkeys is 93.5%. 2 Several lines of evidence suggest that such genetic differences between rodents and primates are mainly attributed to the accelerated evolution of primate brain. 3, 4 Major mental disorders are caused by genetic and environmental factors, and susceptibility genes for these diseases have recently become available. Consistent with the notion of a rapid evolution in genes involved in brain functions, the sequence conservation of the representative susceptibility genes for the mental disorders between humans and mice is not high. 5 One marked example is the G72 gene. 6 As no rodent orthologue for G72 exists, functional studies on G72 have not been well developed. As is evident by the case of G72, difficulty in genetic manipulation of primate models has hampered elucidation of the function of brain proteins encoded by rapidly evolved genes. To overcome this dilemma, we have extended our preliminary study, 7 and established primate brain cultures from cynomolgus monkeys (Macaca fascicularis) in which genes can be transfected by a simple method. First, we further characterized this primary brain culture by immunofluorescent cell staining using several molecular markers. We examined neuronal and glial differentiation in this culture by using antibodies against pan-neurofilament as an axonal marker (Figure 1a) , microtubule-associated protein-2 (MAP2) as a dendritic marker, and glial fibrillary acidic protein (GFAP) as a glial marker (Supplementary Figure 1a) . We confirmed the maintenance of MAP2-positive cells for at least 2 weeks. Under current conditions, glial cell growth becomes prominent 1 week after plating. Neuronal differentiation and maturation were evident by time-course changes in the neuronal progenitor marker, nestin and immature neuron marker, doublecortin (DCX) Table 1 ). The main achievement of this study is to report preparation of gene-transfectable primate brain culture with two practical advantages: first, we can obtain approximately 1-4 Â 10 8 cells per primate fetus at embryonic day 80 (E80), the equivalent cell number from 30 to 120 rat fetuses at E18, by taking a fetus from a pregnant female through cesarean section without killing it. Furthermore, cells can be cryopreserved and stored in aliquots, providing us with brain cultures from the same fetus for use many times. Primary brain cultures from primates have not been widely used, because it is ethically difficult to kill pregnant primates per culture; this is overcome by the present protocol. Second, plasmids are transfectable into cultures by an easy conventional method. There is precedence for introducing genes into primate neurons by an adenovirus system, 8 but this is time consuming and there is background neurotoxicity. Instead, we report an easy method of gene transduction of plasmid transfection by lipofection without observing any robust cytotoxicity. This primate culture will be useful to test functions of the proteins that are rapidly evolved in primates by transfecting them with expression and RNAi constructs. Furthermore, this culture may clarify roles for noncoding RNAs or epigenetic mechanism. These regulatory mechanisms are evolving rapidly in primates. 9 One example is Disrupted-In-Schizophrenia-2 (DISC2), 10 a noncoding antisense RNA to DISC1, which is conserved only between humans and rhesus macaques, but does not exist in rodents. The present primate cultures may permit us to elucidate a role for DISC2 in regulation of DISC1. Taken together, we propose the use of the present method of obtaining brain cultures from primates and introduction of genes into the culture as a novel tool for molecular studies of neuropsychiatric disorders. Telomeres are DNA repeats located at the ends of chromosomes, which progressively shorten with each cell division, thus serving as a molecular biomarker of physical aging in many organisms. 1 Unexpectedly, telomere dysfunction was recently described in psychological stress 2 and mood disorders. 3 These intriguing findings suggest a molecular link between neural activity and aging, and raise the possibility that telomere maintenance may be impaired in other psychiatric disorders.
Here, we tested the hypothesis that telomere dynamics are altered in schizophrenia, a severe psychotic disorder. Subjects with schizophrenia were recruited from two cohorts, A and B, and were evaluated using structured interviews (Supplementary Methods). Telomere lengths were measured in a total of 51 individuals with schizophrenia, 52 unaffected, unrelated individuals, and 24 unaffected family members. Genomic DNA was isolated from peripheral blood lymphocytes and telomere length was measured using quantitative PCR. 4 Significance was evaluated using analysis of variance (ANOVA) or analysis of covariance (ANCOVA) where necessary (Supplementary Methods). Since telomere lengths were quantitated in two independent laboratories, the results were analyzed separately, as described below.
We first examined telomere lengths in 31 individuals diagnosed with schizophrenia (DSM-IV), recruited from the two separate cohorts (A, n = 13; B, n = 18), 41 unrelated individuals screened as having no major psychiatric disorder (Control) and 24 unaffected family members (Family), most of whom were first-degree relatives of cohort B ( Figure  1a ; Supplementary Table S1A). As expected, there was a negative correlation of telomere length with age (r = À0.28, P = 0.01). Since age and sex can affect telomere length, 5 the data were analyzed using an ANCOVA, controlling for the effects of these two variables. We observed a significant main effect of diagnosis (F = 6.44, df = 2, P = 0.002), but there was no main effect of age or sex within this analysis. No significant difference in telomere lengths was observed between the two schizophrenia cohorts, although they were evaluated using different struc- Table  S1A ). *P = 0.002 for Control vs Sz using ln(T/S). (b) T/S was determined for unrelated, unaffected individuals (Control, n = 26) and individuals with schizophrenia (Sz, n = 33) in an age-matched data set containing only male subjects (Supplementary Table S1B ).
# P = 0.008 for Control vs Sz. Means±s.e.m. are depicted.
